Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.24 HKD
Change Today +0.34 / 37.78%
Volume 16.5M
As of 4:01 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

wanjia group holdings ltd (401) Snapshot

Open
$0.94
Previous Close
$0.90
Day High
$1.28
Day Low
$0.94
52 Week High
05/29/15 - $1.28
52 Week Low
12/8/14 - $0.39
Market Cap
804.0M
Average Volume 10 Days
6.6M
EPS TTM
$0.08
Shares Outstanding
648.4M
EX-Date
--
P/E TM
16.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for WANJIA GROUP HOLDINGS LTD (401)

Related News

No related news articles were found.

wanjia group holdings ltd (401) Related Businessweek News

No Related Businessweek News Found

wanjia group holdings ltd (401) Details

Wanjia Group Holdings Limited wholesales and distributes pharmaceutical products; and operates a chain of retail pharmacies in the People’s Republic of China. The company sells its pharmaceutical products to hospitals and healthcare institutions; distributor customers; and end customers, such as companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics in the Fujian, Guangdong, Hunan, Hubei, Jiangxi, Aunhui, and Zhejiang provinces. Its pharmaceutical retail pharmacies offer prescription medicines, over-the-counter medicines, healthcare food products, traditional Chinese medicines, medical supplies, and medical devices. As of March 31, 2014, the company had 115 retail pharmacies in Fujian province under the Huihao Sihai brand name. The company was founded in 2004 and is headquartered in Hong Kong, Hong Kong. Wanjia Group Holdings Limited is a subsidiary of Greatly Wealth Global Group Limited.

1,176 Employees
Last Reported Date: 06/27/14
Founded in 2004

wanjia group holdings ltd (401) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

wanjia group holdings ltd (401) Key Developments

Wanjia Group Holdings Limited Announces Board Changes

The Board of Wanjia Group Holdings Limited announced that Mr. Yung Ka Chun has tendered his resignation as an executive Director, member of the remuneration committee and an authorized representative of the company with effect from 20 April 2015. The Board further announced that Ms. Shum Ngai Pan has been appointed as an executive Director and an authorized representative of the company with effect from 20 April 2015.

Wanjia Group Holdings Limited Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Wanjia Group Holdings Limited reported unaudited consolidated earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company has posted turnover of HKD 407,486,000 against HKD 497,809,000 a year ago. Profit from operations was HKD 6,875,000 against HKD 18,875,000 a year ago. Profit before taxation was HKD 4,472,000 against HKD 17,421,000 a year ago. Profit for the period attributable to owners of the company was HKD 3,164,000 or 0.488 cents basic and diluted per share against HKD 10,985,000 or 1.694 cents basic and diluted per share a year ago. Profit was HKD 2,938,000 compared to HKD 11,025,000 a year ago. For the nine months, the company has posted turnover of HKD 1,249,240,000 against HKD 1,567,179,000 a year ago. The decrease in turnover was mainly attributable to decrease in revenue generated from the pharmaceutical wholesales segment as a result of the promulgation and implementation of new Good Supply Practice in Fujian, the People's Republic of China in April 2014 which imposes stringent regulations on pharmaceutical distributor operation. Loss from operations was HKD 761,861,000 against profit from operations of HKD 54,614,000 a year ago. Loss before taxation was HKD 768,291,000 against profit before taxation of HKD 50,759,000 a year ago. Loss for the period attributable to owners of the company was HKD 775,020,000 or 120 cents basic and diluted per share against profit for the period attributable to owners of the company of HKD 31,368,000 or 4.838 cents basic and diluted per share a year ago. Loss was HKD 775,466,000 compared to profit of HKD 31,481,000 a year ago.

Wanjia Group Holdings Limited Announces Resignation of Weng Jiaxing as Executive Director, Effective on November 21, 2014

Wanjia Group Holdings Limited announced that Weng Jiaxing, Executive Director has resigned. The effective date is November 21, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
401:HK $1.24 HKD +0.34

401 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Nepstar Chain Drugstore Ltd $2.70 USD 0.00
Huadong Medicine Co Ltd CNY76.00 CNY +0.87
Jointown Pharmaceutical Group Co Ltd CNY29.37 CNY -0.95
Nanjing Pharmaceutical Co Ltd CNY17.00 CNY +0.96
View Industry Companies
 

Industry Analysis

401

Industry Average

Valuation 401 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.5x
Price/Book 3.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WANJIA GROUP HOLDINGS LTD, please visit www.wanjia-gp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.